Acadia Healthcare (ACHC) Debt Trading 1% Higher

An issue of Acadia Healthcare Company Inc (NASDAQ:ACHC) bonds rose 1% as a percentage of their face value during trading on Friday. The debt issue has a 5.625% coupon and is set to mature on February 15, 2023. The bonds in the issue are now trading at $100.50 and were trading at $99.00 one week ago. Price moves in a company’s bonds in credit markets often anticipate parallel moves in its share price.

Several equities research analysts have recently issued reports on ACHC shares. Mizuho set a $37.00 target price on Acadia Healthcare and gave the company a “hold” rating in a research report on Tuesday, August 28th. Craig Hallum lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday. They noted that the move was a valuation call. BidaskClub lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, September 13th. ValuEngine raised Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research report on Thursday, July 26th. Finally, BMO Capital Markets lowered Acadia Healthcare from an “outperform” rating to a “market perform” rating and set a $45.00 target price for the company. in a research report on Wednesday, August 1st. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the company. Acadia Healthcare has an average rating of “Hold” and a consensus price target of $44.36.

ACHC traded down $0.17 during trading hours on Friday, hitting $38.40. The stock had a trading volume of 1,869,500 shares, compared to its average volume of 1,162,919. Acadia Healthcare Company Inc has a 1 year low of $26.92 and a 1 year high of $45.27. The firm has a market cap of $3.16 billion, a P/E ratio of 16.99, a price-to-earnings-growth ratio of 1.28 and a beta of 0.63. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.24 and a current ratio of 1.24.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Monday, July 30th. The company reported $0.70 earnings per share for the quarter, hitting the consensus estimate of $0.70. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company had revenue of $765.70 million during the quarter, compared to analyst estimates of $767.93 million. During the same quarter last year, the firm posted $0.66 EPS. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, research analysts predict that Acadia Healthcare Company Inc will post 2.52 earnings per share for the current fiscal year.

In related news, Director Reeve B. Waud sold 8,135 shares of Acadia Healthcare stock in a transaction dated Thursday, July 26th. The stock was sold at an average price of $45.00, for a total value of $366,075.00. Following the completion of the sale, the director now owns 14,213 shares of the company’s stock, valued at approximately $639,585. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 11.10% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Alpine Woods Capital Investors LLC purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $153,000. New Jersey Better Educational Savings Trust purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $205,000. Cubist Systematic Strategies LLC purchased a new position in Acadia Healthcare during the 1st quarter valued at about $255,000. Bbva Compass Bancshares Inc. purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $259,000. Finally, Strs Ohio purchased a new position in Acadia Healthcare during the 3rd quarter valued at about $308,000.

Acadia Healthcare Company Profile (NASDAQ:ACHC)

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Recommended Story: Conference Calls

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply